Cancer cure for 32 cancer types: results from the EUROCARE-5 study.

Publication date: Sep 28, 2020

Few studies have estimated the probability of being cured for cancer patients. This study aims to estimate population-based indicators of cancer cure in Europe by type, sex, age and period.

7.2 million cancer patients (42 population-based cancer registries in 17 European countries) diagnosed at ages 15-74 years in 1990-2007 with follow-up to 2008 were selected from the EUROCARE-5 dataset. Mixture-cure models were used to estimate: (i) life expectancy of fatal cases (LEF); (ii) cure fraction (CF) as proportion of patients with same death rates as the general population; (iii) time to cure (TTC) as time to reach 5-year conditional relative survival (CRS) >95%.

LEF ranged from 10?years for chronic lymphocytic leukaemia patients to 5?years for women with breast cancer. The CF was 94% for testis, 87% for thyroid cancer in women and 70% in men, 86% for skin melanoma in women and 76% in men, 66% for breast, 63% for prostate and

Concepts Keywords
Breast Skin melanoma
Breast Cancer Health
Chronic Lymphocytic Leukaemia Medicine
Conditional Articles
Europe Epidemiology
LEF Eurocare
Melanoma Temperance movement
Probability Cure
Prostate Serraino
Testis Breast cancer
Thyroid Relative survival


Type Source Name
disease MESH Cancer
disease MESH death
disease MESH breast cancer
pathway KEGG Breast cancer
disease MESH thyroid cancer
pathway KEGG Thyroid cancer
disease MESH men
disease MESH melanoma
pathway KEGG Melanoma

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *